Evaxion Biotech A/S
Stock Forecast, Prediction & Price Target
Evaxion Biotech A/S Financial Estimates
Evaxion Biotech A/S Revenue Estimates
Evaxion Biotech A/S EBITDA Estimates
Evaxion Biotech A/S Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $73K 0% | Avg: $13.75M Low: $13.73M High: $13.77M avg. 18741.78% | Avg: $63.58M Low: $63.50M High: $63.67M avg. 362.29% | Avg: $29.12M Low: $29.09M High: $29.16M avg. -54.19% | Avg: $91.04M Low: $90.93M High: $91.17M avg. 212.59% |
Net Income
% change YoY
| $-24.53M N/A | $-23.16M 5.55% | $-22.12M 4.50% | Avg: $-5.76M Low: $-9.13M High: $3.55M avg. 73.95% | Avg: $30.90M Low: $16.92M High: $16.97M avg. 636.22% | Avg: $355.36K Low: $354.79K High: $356.02K avg. -98.85% | Avg: $10.11M Low: $10.09M High: $10.13M avg. 2746.16% |
EBITDA
% change YoY
| $-23.79M N/A | $-22.43M 5.72% | $-21.40M 4.59% | Avg: $8.25M Low: $8.24M High: $8.26M avg. 138.55% | Avg: $38.15M Low: $38.10M High: $38.20M avg. 362.29% | Avg: $17.47M Low: $17.45M High: $17.50M avg. -54.19% | Avg: $54.62M Low: $54.56M High: $54.70M avg. 212.59% |
EPS
% change YoY
| -$12.58 N/A | -$9.8 22.09% | -$8.11 17.24% | Avg: -$1.58 Low: -$3.34 High: $1.3 avg. 80.51% | Avg: $6.2 Low: $6.19 High: $6.21 avg. 492.40% | Avg: $0.13 Low: $0.13 High: $0.13 avg. -97.90% | Avg: $3.7 Low: $3.69 High: $3.71 avg. 2746.15% |
Operating Expenses
% change YoY
| $25.83M N/A | $25.26M -2.20% | $22.24M -11.94% | Avg: $390.81M Low: $390.34M High: $391.37M avg. 1656.88% | Avg: $1.80B Low: $1.80B High: $1.80B avg. 362.29% | Avg: $827.60M Low: $826.60M High: $828.78M avg. -54.19% | Avg: $2.58B Low: $2.58B High: $2.59B avg. 212.59% |
FAQ
What is Evaxion Biotech A/S stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 839.37% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -9.13M, average is -5.76M and high is 3.55M.
What is Evaxion Biotech A/S stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 4815.61% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $13.73M, average is $13.75M and high is $13.77M.
What is Evaxion Biotech A/S stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 805.29% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.34, average is -$1.58 and high is $1.3.